Welcome to our dedicated page for Lifevantage Corporation news (Ticker: $LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Lifevantage Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Lifevantage Corporation's position in the market.
Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) reported a 3.8% decrease in revenue for the second fiscal quarter ended December 31, 2023, but showed improvement in profitability with adjusted EBITDA increasing by 289% to $3.1 million. The company also announced a cash dividend of $0.035 per common share and expects revenue in the range of $207 million to $213 million for fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.92%
Tags
-
Rhea-AI Summary
LifeVantage Corporation (LFVN) will release financial results for its second quarter ended December 31, 2023. The conference call for investors will be held on Tuesday, January 30, 2024, at 2:30 p.m. Mountain Time. The company's webcast will be available on the Investor Relations section of the Company's website. Investors can dial (877) 704-4453 from the U.S. or (201) 389-0920 for international calls to participate in the live call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
-
Rhea-AI Summary
LifeVantage Corporation held its annual Global Kickoff event, announcing the 'Rise ERA' theme, new sales incentives, and the launch of new Consultant tools. The company is focused on enrolling, retaining, and advancing as part of its strategic transformation, with plans for international expansion and growth. The event also introduced the Rise ERA Incentive and Executive Destination Trip, as well as the upcoming launch of LV360 Phase 2 in Mexico, Canada, and Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.29%
Tags
Rhea-AI Summary
LifeVantage Corporation (LFVN) CEO and CFO to Participate in Water Tower Research Fireside Chat Series on December 14, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
-
Rhea-AI Summary
LifeVantage Corporation (LFVN) announced a study on the impact of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen on cellular health. The study showed that the products work together to help cells respond to stress levels and recover more quickly, supporting the body’s immune function. This emphasizes the company's unique approach to health and wellness through scientific research and product differentiation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
-
Rhea-AI Summary
LifeVantage Corporation (LFVN) appoints Raymond Greer as Chairman of the Board, succeeding Garry Mauro. The company aims to revamp management and shape a comprehensive strategic transformation for future growth and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.6%
Tags
News
Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) announced the final, certified results of its fiscal year 2024 annual meeting of stockholders, confirming the re-election of all seven incumbent directors. The company expressed gratitude for the high turnout and stockholder support, highlighting the approval of all proposals, including the stockholders rights plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.02%
Tags
-
Rhea-AI Summary
LifeVantage Corporation (LFVN) announces approval of $0.035 quarterly cash dividend, payable on December 15, 2023, to stockholders of record on December 1, 2023, emphasizing commitment to shareholder value and financial stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.73%
Tags
-
Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) reported Q1 fiscal 2024 revenue of $51.4 million, down 0.8% YoY. Americas revenue increased 5.9%, U.S. revenue up 6.5%, but Asia/Pacific & Europe revenue decreased 16.6%. Total active accounts declined 10.5% YoY to 137,000. Adjusted EBITDA increased 41.4% to $4.0 million. The company announced a cash dividend of $0.035 per common share and expects FY 2024 revenue of $216-226 million and adjusted EBITDA of $16-18 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.73%
Tags
Rhea-AI Summary
LifeVantage Corporation has announced the launch of TrueScience TrueRenew Daily Firming Complex, an innovative retinol-alternative skincare product. TrueRenew is designed to complement the brand's existing products and tackle 11 visible signs of aging. The global retinol market is expected to reach $1.79 billion by 2030, and TrueRenew aims to capitalize on the rising consumer demand for retinol alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
Lifevantage Corporation
Nasdaq:LFVN
LFVN Rankings
LFVN Stock Data
78.63M
8.95M
16.35%
28.68%
0.49%
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
LEHI
About LFVN
lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.